All simulation input files, analysis scripts, and unbiased trajectories discussed in this work can be found on Zenodo with the following DOI: [10.5281/zenodo.1035202](https://doi.org/10.5281/zenodo.1035202).

Introduction {#sec001}
============

Cholesterol, ubiquitously present in all vertebrate cells, regulates the structure and permeability of cellular membranes \[[@pcbi.1005831.ref001], [@pcbi.1005831.ref002]\]. It comprises typically 20--25 mol % of all lipids in the plasma membrane \[[@pcbi.1005831.ref001]\] and acts as a precursor for many bioactive molecules such as steroid hormones, bile acids, oxysterols, and vitamin D \[[@pcbi.1005831.ref002]\]. While cholesterol is vital for health, its excessive accumulation results in pathologies, such as cardiovascular diseases, the complications of which account for about 30% of deaths globally \[[@pcbi.1005831.ref002]\]. Because most cells cannot catabolize cholesterol, its efflux is crucial to prevent cholesterol overloading \[[@pcbi.1005831.ref002]\].

There is a network of cellular signaling and transport systems that tightly controls cholesterol trafficking \[[@pcbi.1005831.ref001]\]. One of the key proteins involved in cholesterol efflux from late endosomes/lysosomes is Niemann-Pick Protein C2 ([npc]{.smallcaps}2), an intralysosomal and secretory protein found in epididymal fluid, milk, plasma, and the bile \[[@pcbi.1005831.ref003]\]. Mutations in [npc]{.smallcaps}2 or its transmembrane partner [npc]{.smallcaps}1 result in accumulation of lipids such as unesterified cholesterol and sphingolipids \[[@pcbi.1005831.ref004], [@pcbi.1005831.ref005]\]. This fatal genetic lysosomal storage condition called Niemann-Pick C disease results in progressive neuronal degeneration in the brain and early death \[[@pcbi.1005831.ref006], [@pcbi.1005831.ref007]\].

In the late endosome/lysosome, a "tag team duo" composed of [npc]{.smallcaps}1 and [npc]{.smallcaps}2 is responsible for egress of endocytosed cholesterol \[[@pcbi.1005831.ref004], [@pcbi.1005831.ref008]\]. [npc]{.smallcaps}2 captures cholesterol from the internal membranes of late endosomes/lysosomes and transfers it to [npc]{.smallcaps}1 \[[@pcbi.1005831.ref009], [@pcbi.1005831.ref010]\] for cholesterol egress from these compartments \[[@pcbi.1005831.ref005]\]. There has been recent resurgence of [npc]{.smallcaps}1 structures characterized by crystallography and cryo-electron microscopy \[[@pcbi.1005831.ref011]--[@pcbi.1005831.ref015]\], reviving interest in molecular investigation of late endosomal/lysosomal cholesterol trafficking. These structural studies have been complemented by computational investigations focused on the cholesterol transfer process between the N-terminal domain of [npc]{.smallcaps}1 and [npc]{.smallcaps}2 \[[@pcbi.1005831.ref016], [@pcbi.1005831.ref017]\], as well as sterol-binding to [npc]{.smallcaps}2 \[[@pcbi.1005831.ref018]\].

Meanwhile, [npc]{.smallcaps}2 also works independently of [npc]{.smallcaps}1 \[[@pcbi.1005831.ref019]\]. In particular, it has been shown that normalizing [abca]{.smallcaps}1 expression can bypass the effects of [npc]{.smallcaps}1 mutations, but not those of [npc]{.smallcaps}2 mutations \[[@pcbi.1005831.ref020]\], highlighting the importance of the [npc]{.smallcaps}1-independent cholesterol transport by [npc]{.smallcaps}2. In this work, we investigate the [npc]{.smallcaps}1-independent mechanism, namely the direct specific binding of [npc]{.smallcaps}2 onto the internal late endosomal/lysosomal membranes to cargo cholesterol between them \[[@pcbi.1005831.ref019], [@pcbi.1005831.ref021]\].

[npc]{.smallcaps}2 mainly functions in the acidic environment of late endosomes and lysosomes. These organelles manifest a multivesicular appearance due to the presence of a unique anionic phospholipid called bis(monoacylglycero)phosphate ([bmp]{.smallcaps}), also known as lysobisphosphatidic acid ([lbpa]{.smallcaps}) \[[@pcbi.1005831.ref022]\]. [bmp]{.smallcaps} is abundant within the internal membranes of late endosomes/lysosomes, yet it is absent from the cytoplasmic leaflet of the limiting membrane \[[@pcbi.1005831.ref022]\]. The intraluminal vesicles are the sites of sphingolipid degradation, with sphingomyelin ([sm]{.smallcaps}) representing the most abundant sphingolipid \[[@pcbi.1005831.ref023]\]. When bound to a membrane, [npc]{.smallcaps}2 interacts specifically with [bmp]{.smallcaps}, which modulates its efficiency in cholesterol transport \[[@pcbi.1005831.ref021], [@pcbi.1005831.ref024]--[@pcbi.1005831.ref026]\]. On the other hand, [sm]{.smallcaps} strongly inhibits cholesterol transfer by [npc]{.smallcaps}2 \[[@pcbi.1005831.ref027]\]. Nevertheless, the molecular interactions between [npc]{.smallcaps}2 and different lipid components, and in particular how [bmp]{.smallcaps} and [sm]{.smallcaps} contributes to this dual regulation of [npc]{.smallcaps}2-dependent cholesterol transport remain unclear.

We used atomistic molecular dynamics (MD) simulations to perform an extensive investigation of [npc]{.smallcaps}2-membrane interactions in a variety of different membrane lipid mixtures of neutral (1-palmitoyl-2-oleoyl-*sn*-glycero-3-phosphocholine ([popc]{.smallcaps}), N-palmitoyl-D-*erythro*-sphingosylphosphorylcholine ([sm]{.smallcaps})) and charged (s-s 2,2'-dioleoyl lysobisphosphatidic acid ([bmp]{.smallcaps}), 1,2-dioleoyl-*sn*-glycero-3-phosphatidylglycerol ([dopg]{.smallcaps})) lipids together with cholesterol ([chol]{.smallcaps}). We determined the lipid-dependent membrane-binding free energies using *well-tempered metadynamics* ([wt]{.smallcaps}-[mtd]{.smallcaps}) on three *collective variables* ([cv]{.smallcaps}s) that define the orientation and the position of [npc]{.smallcaps}2 with respect to the membrane. The results highlight that i) [npc]{.smallcaps}2 binds charged membranes favorably; ii) [npc]{.smallcaps}2 binds membranes in two different competitively favorable orientations; iii) [bmp]{.smallcaps} is decisive for strong [npc]{.smallcaps}2 binding in the orientation that places the cholesterol-binding pocket of [npc]{.smallcaps}2 in direct contact with the membrane; and iv) [sm]{.smallcaps} hinders the formation of the aforementioned orientation. We characterized specific lipid-protein interactions in different orientations to understand the bases of the observed binding and inhibition mechanisms induced by [bmp]{.smallcaps} and [sm]{.smallcaps}. Altogether, the results provide an atom-scale picture for [npc]{.smallcaps}2-membrane binding and insights into how the membrane composition modulates the efficiency of [npc]{.smallcaps}2-dependent cholesterol transport.

Materials and methods {#sec002}
=====================

We considered a total of 8 different membrane systems (see [Table 1](#pcbi.1005831.t001){ref-type="table"}) composed of [bmp]{.smallcaps}, [chol]{.smallcaps}, [sm]{.smallcaps}, [dopg]{.smallcaps}, and [popc]{.smallcaps}. For 5 of these membrane systems (systems 1, 3--5, 7 in [Table 1](#pcbi.1005831.t001){ref-type="table"}), we performed unbiased simulations with [npc]{.smallcaps}2 in its cholesterol-bound ([npc]{.smallcaps}2^[chol]{.smallcaps}-bound^) and *apo* ([npc]{.smallcaps}2^*apo*^) forms. Seven 400 ns long repeats were performed, each starting from a randomly chosen independent initial configuration, adding up to a total of 70 unbiased simulations. We also performed (biased) free energy calculations using well-tempered metadynamics ([wt]{.smallcaps}-[mtd]{.smallcaps}) \[[@pcbi.1005831.ref028]\] for all membrane systems except System 4 with [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^ and [npc]{.smallcaps}2^*apo*^. The total simulation time for unbiased and biased simulations add up to 28 *μ*s and ∼148 *μ*s, respectively.

10.1371/journal.pcbi.1005831.t001

###### Description of the simulated systems and a summary of the main results as to binding processes.

![](pcbi.1005831.t001){#pcbi.1005831.t001g}

  System   Membrane Composition/(mol%)   No. observations   Free Energy/(kJ/mol)                                                                                                                                     
  -------- ----------------------------- ------------------ ---------------------- ---- ---- ----------------- ----------- ----------- ----------- ----------------- ----------- ----------- ----------- ----------- -----------
  1        0                             10                 0                      0    90   0                 0           0           0           -0.5±0.7          1.1±0.6     0.9±0.5     0.2±0.5     -0.8±0.5    0.7±0.4
  2        0                             35                 0                      0    65   *not performed*   1.9±0.5     1.4±0.5     1.4±0.4     0.6±0.4           -0.4±0.3    0.7±0.3                             
  3        0                             10                 20                     0    70   0                 1           0           0           -0.4±0.5          -0.2±0.5    -0.1±0.4    0.4±0.5     -0.5±0.5    0.6±0.4
  4        100                           0                  0                      0    0    1                 6           1           6           *not performed*                                                   
  5        20                            10                 0                      0    70   1                 6           0           0           -11.5±0.8         -11.9±0.7   -10.6±0.6   -10.5±0.8   -12.0±0.8   -10.1±0.7
  6        20                            35                 0                      0    45   *not performed*   -10.8±0.8   -14.9±0.7   -12.3±0.6   -10.0±0.6         -12.4±0.6   -10.1±0.6                           
  7        20                            10                 20                     0    50   0                 5           0           4           -7.5±1.0          -12.2±1.0   -9.7±0.9    -8.8±0.8    -11.9±0.7   -10.0±0.8
  8        0                             10                 0                      20   70   *not performed*   -6.2±0.7    -8.5±0.7    -6.6±0.5    -7.6±0.7          -9.9±0.7    -8.1±0.7                            

Membrane content is given in terms of molar fractions for a mixture of [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps}. No. observations lists the number of unbiased simulations out of 7 repeats, in which *Prone* or *Supine mode* formed. Free energy contribution to binding for each orientation is also shown based on the free energy calculations (see [S1 Text](#pcbi.1005831.s001){ref-type="supplementary-material"} for the details on how the values are obtained). The phrase *not performed* specifies that the simulations were not performed for that particular membrane composition.

The preparation of all systems including the membrane mixtures is described in detail in [S1 Text](#pcbi.1005831.s001){ref-type="supplementary-material"}. All simulations were performed using [gromacs]{.smallcaps} 5.0 \[[@pcbi.1005831.ref029]\] employing the Amber ff99sb-[ildn]{.smallcaps} force field \[[@pcbi.1005831.ref030]\] for the protein, the Slipids force field \[[@pcbi.1005831.ref031]\] for the lipids, and the [tip3p]{.smallcaps} model for water \[[@pcbi.1005831.ref032]\].

The equations of motion were integrated using a leap-frog algorithm with a 2 fs time step. All bonds were constrained using the [lincs]{.smallcaps} algorithm \[[@pcbi.1005831.ref033]\]. Long-range electrostatic interactions were treated by the smooth particle mesh Ewald scheme ([spme]{.smallcaps}) \[[@pcbi.1005831.ref034], [@pcbi.1005831.ref035]\] with a real-space cutoff of 1.0 nm, a Fourier spacing of 0.16 nm, and a fourth-order interpolation. The van der Waals interactions were treated with a Lennard-Jones potential with a cutoff of 1.0 nm. Long-range dispersion corrections were applied for energy and pressure \[[@pcbi.1005831.ref036]\].

Before production runs, successive steepest descent minimizations were carried out, followed by short equilibration simulations in the *NVT* and *NpT* ensembles at a temperature of 310°K using the v-rescale thermostat \[[@pcbi.1005831.ref037]\] with a time constant of 0.1 ps. The pressure was kept at 1 atmosphere using the Berendsen barostat \[[@pcbi.1005831.ref038]\] with a time constant of 0.5 ps.

All production simulations were performed in the *NpT* ensemble. Protein, solvent (water and ions), and lipids were coupled to separate temperature baths at 310°K using the Nosé-Hoover thermostat \[[@pcbi.1005831.ref039], [@pcbi.1005831.ref040]\] with a time constant of 0.5 ps. Pressure was kept at 1 atmosphere with a time constant of 10 ps and a compressibility of 4.5 × 10^−5^ bar^−1^ using the Parrinello-Rahman barostat \[[@pcbi.1005831.ref041], [@pcbi.1005831.ref042]\] semi-isotropically for membrane-containing systems and isotropically for others.

For the free energy calculations, all biased simulations employed [gromacs]{.smallcaps} 5.0.4 \[[@pcbi.1005831.ref029]\] patched with [plumed]{.smallcaps} 2.1 \[[@pcbi.1005831.ref043]\]. Details of these free energy computations are discussed in [S1 Text](#pcbi.1005831.s001){ref-type="supplementary-material"}, which also includes a more detailed description of the simulation protocol.

Results {#sec003}
=======

[npc]{.smallcaps}2 binds anionic [bmp]{.smallcaps}-containing membranes in two distinct binding modes {#sec004}
-----------------------------------------------------------------------------------------------------

To investigate the role of [bmp]{.smallcaps}, [sm]{.smallcaps}, and [chol]{.smallcaps} in [npc]{.smallcaps}2--membrane binding, we prepared a number of membrane models with different lipid compositions listed in [Table 1](#pcbi.1005831.t001){ref-type="table"}. For most of the membrane systems, we first carried out unbiased [md]{.smallcaps} simulations, where we initially placed *apo* ([npc]{.smallcaps}2^*apo*^) \[[@pcbi.1005831.ref044]\] or [chol]{.smallcaps}-bound [npc]{.smallcaps}2 ([npc]{.smallcaps}2^[chol]{.smallcaps}-bound^) \[[@pcbi.1005831.ref003]\] above the membrane surface in seven different, randomly chosen orientations such that the minimum *z*-distance between the protein and the membrane surface is 30--35Å (see [Fig 1A](#pcbi.1005831.g001){ref-type="fig"} for a typical initial configuration). In these unbiased simulations, the membranes containing [bmp]{.smallcaps} ([bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps} = 100:0:0:0:0 (System 4), 20:10:0:0:70 (System 5), and 20:10:20:0:50 (System 7)) resulted in spontaneous association of [npc]{.smallcaps}2 with the membrane in less than 60 ns ([Fig 1B and 1C](#pcbi.1005831.g001){ref-type="fig"}). For comparison, if the membrane considered did not include [bmp]{.smallcaps} ([bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps} = 0:10:0:0:90 (1) and 0:10:20:0:70 (System 3)), then no [npc]{.smallcaps}2 binding was observed. The only exception was [chol]{.smallcaps}:[sm]{.smallcaps}:[popc]{.smallcaps} = 10:20:70, where one out of 14 simulations resulted in [npc]{.smallcaps}2 binding to the membrane.

![Snapshots of simulated system with a lipid composition of [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps} = 20:10:0:0:70 (System 5).\
A) A typical starting configuration for [npc]{.smallcaps}2 in the water phase, above the membrane. B) Final configuration after a simulation of 400 ns in a case, where the cholesterol-binding pocket faces the membrane (*Prone mode*). C) Final configuration of a simulation, where the cholesterol-binding pocket faces the water phase (*Supine mode*). The residue G61 residing at the opening of the binding pocket is highlighted. Color code for lipids: [bmp]{.smallcaps} (violet), [chol]{.smallcaps} (green), [popc]{.smallcaps} (light brown). For clarity's sake, water is not shown.](pcbi.1005831.g001){#pcbi.1005831.g001}

Monitoring the distance between the membrane surface and the residue at the opening of the cholesterol-binding pocket (G61), we observed that [npc]{.smallcaps}2 binds the membranes in two distinct modes based on the membrane-adsorbed state: membrane binding orientation 1 (*Prone mode*, [Fig 1B](#pcbi.1005831.g001){ref-type="fig"}), in which the cholesterol-binding pocket is in direct contact with the membrane surface and G61 is inserted into the membrane; and orientation 2 (*Supine mode*, [Fig 1C](#pcbi.1005831.g001){ref-type="fig"}), in which G61 is facing away from the membrane surface. *Supine mode*, formed by rotating the protein ∼180° along its long axis with respect to *Prone mode*, places the cholesterol-binding pocket away from the membrane to face the water phase. In these simulations, *Supine mode* is observed more frequently than *Prone mode* for both [npc]{.smallcaps}2^*apo*^ and [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^ ([Table 1](#pcbi.1005831.t001){ref-type="table"}) and the orientations do not interconvert within 400 ns. [Table 1](#pcbi.1005831.t001){ref-type="table"} shows the number of times each orientation is observed for each membrane system based on the location of G61 with respect to the membrane surface.

Based on the results, one can conclude that i) the simulations reveal two functional binding modes with favorable energetics, and ii) the [npc]{.smallcaps}2-membrane interaction is so strong that once the binding has taken place, the protein is trapped in one of the two local minima and the orientation does not change during the simulation time scale of 400 ns.

[npc]{.smallcaps}2 changes binding orientation by rocking around its long axis {#sec005}
------------------------------------------------------------------------------

Characterizing the aforementioned membrane binding modes both energetically (to compute the free energy of binding) and structurally (to determine the mechanism of binding) requires extensive sampling of the relevant degrees of freedom. To this end, we used a combination of well-tempered metadynamics ([wt]{.smallcaps}-[mtd]{.smallcaps}) \[[@pcbi.1005831.ref028]\], umbrella sampling, and bias exchange \[[@pcbi.1005831.ref045]\]. A similar combination of [wt]{.smallcaps}-[mtd]{.smallcaps} and umbrella sampling was previously used in coarse-grained simulations \[[@pcbi.1005831.ref046]\].

A schematic representation of our sampling approach is shown in [Fig 2](#pcbi.1005831.g002){ref-type="fig"} and the details can be found in [S1 Text](#pcbi.1005831.s001){ref-type="supplementary-material"}. Briefly, we defined three collective variables ([cv]{.smallcaps}s) that describe the position and the orientation of the protein with respect to the membrane:

1.  \|*z*\|: projection of the distance between the center of mass ([com]{.smallcaps}) of the P atoms of the membrane upper leaflet and the [com]{.smallcaps} of C~*α*~ atoms of the protein on to the *z*-axis, the coordinate along the membrane normal direction. This collective variable describes the [npc]{.smallcaps}2-membrane distance.

2.  *θ*: angle between the long axis of the protein and the membrane normal ([Fig 2A](#pcbi.1005831.g002){ref-type="fig"}), thereby describing the principal orientation of [npc]{.smallcaps}2 with respect to the membrane surface.

3.  *ϕ*: the angle between the short axis of the protein and the membrane normal ([Fig 2B](#pcbi.1005831.g002){ref-type="fig"}). Together, the angles *θ* and *ϕ* uniquely define the protein orientation at the membrane surface.

![The collective variables and the sampling approach.\
[npc]{.smallcaps}2 structure overlaid with vectors showing the long (A) and the short (B) axes of the protein and the collective variables *θ* (A) and *ϕ* (B). The membrane normal defined as the vector between the [com]{.smallcaps} of P atoms of the upper and the lower leaflets of the membrane is represented with a solid arrow. A) The long axis is defined as a vector connecting the C~*α*~ [com]{.smallcaps} of residues 1--6, 19--38, 55--69, 93--109, 123--130 (pink), and that of residues 7--18, 39--54, 70--92, 110--122 (blue). B) The short axis is defined as a vector connecting the C~*α*~ [com]{.smallcaps} of residues 1--6, 13--45, 75--94, 124--130 (pink), and and that of residues 7--12, 46--74, 95--123 (blue). C) A schematic representation of the sampling approach. The numbers indicate the replica indices (*i*). Three separate [wt]{.smallcaps}-[mtd]{.smallcaps} simulations biasing \|*z*\| (*i* = 0, 3, ...), *θ* (*i* = 1, 4, ...), and *ϕ* (*i* = 2, 5, ...) were performed within each window (*w*, shown in different colors) flanked by half harmonic restraints. Bias exchanges were attempted between simulations *i* and *i* + 1 in even (solid arrows) and odd pairings (dashed arrows). For a detailed discussion of the sampling procedure, see [S1 Text](#pcbi.1005831.s001){ref-type="supplementary-material"}.](pcbi.1005831.g002){#pcbi.1005831.g002}

We divided the \|*z*\| range that extends from the membrane surface to bulk solvent into 4Å windows that overlap 1Å with each other using half harmonic restraints. Within each window, we performed three separate [wt]{.smallcaps}-[mtd]{.smallcaps} simulations \[[@pcbi.1005831.ref028]\], in each biasing one of \|*z*\|, *θ*, or *ϕ*. This adds up to 51--54 200 ns-long simulations (17--18 windows) for each system. To further improve the sampling efficiency, we coupled the neighboring simulations through the bias exchange scheme \[[@pcbi.1005831.ref045]\] as shown in [Fig 2](#pcbi.1005831.g002){ref-type="fig"}. [wt]{.smallcaps}-[mtd]{.smallcaps} helps overcome barriers along \|*z*\|, *ϕ*, and *θ* by flattening the underlying free energy landscape, while half-harmonic restraints keep sampling within manageable blocks. Besides, bias exchange improves the statistical efficiency and the convergence of the free energy estimations. This approach allows reconstruction of potential of mean force ([pmf]{.smallcaps}) profiles for complex systems using a reweighting scheme that combines a time-independent locally-converging free energy estimator for metadynamics \[[@pcbi.1005831.ref047]\] and a non-parametric variant of the weighted histogram analysis method \[[@pcbi.1005831.ref048]\], discussed in [S1 Text](#pcbi.1005831.s001){ref-type="supplementary-material"}.

Based on these free energy simulations, we reconstructed one-dimensional (1[d]{.smallcaps}) and two-dimensional (2[d]{.smallcaps}) [pmf]{.smallcaps} profiles for each simulated system as functions of the biased collective variables (see [S1 Text](#pcbi.1005831.s001){ref-type="supplementary-material"} for details). All reconstructed free energy surfaces and their errors are given separately for the anionic and neutral membranes. 1[d]{.smallcaps} [pmf]{.smallcaps}s as a function of \|*z*\| are given in [S1A Fig](#pcbi.1005831.s002){ref-type="supplementary-material"}. 2[d]{.smallcaps} [pmf]{.smallcaps}s and their local errors for \|*z*\| vs *ϕ* are given in [S1B](#pcbi.1005831.s002){ref-type="supplementary-material"} and [S2](#pcbi.1005831.s003){ref-type="supplementary-material"} Figs for anionic membranes and in [S3B](#pcbi.1005831.s004){ref-type="supplementary-material"} and [S4](#pcbi.1005831.s005){ref-type="supplementary-material"} Figs for neutral membranes. The [pmf]{.smallcaps}s for \|*z*\| vs *θ* are given in [S5B](#pcbi.1005831.s006){ref-type="supplementary-material"} and [S6](#pcbi.1005831.s007){ref-type="supplementary-material"} Figs for anionic membranes and in [S7B](#pcbi.1005831.s008){ref-type="supplementary-material"} and [S8](#pcbi.1005831.s009){ref-type="supplementary-material"} Figs for neutral membranes. To capture the depth of insertion into the membrane, we set the origin (*z* = 0) to the *z*-coordinate of the center of mass ([com]{.smallcaps}~*z*~) of the upper leaflet P atoms and reconstructed the [pmf]{.smallcaps}s also as functions of the minimum of the protein C~*α*~ *z*-coordinates, which is here denoted as min *z*~*r*~, *r* being the residue number. See [Fig 3A](#pcbi.1005831.g003){ref-type="fig"} for 1[d]{.smallcaps} [pmf]{.smallcaps}s, [Fig 3B](#pcbi.1005831.g003){ref-type="fig"} and [S9 Fig](#pcbi.1005831.s010){ref-type="supplementary-material"} for 2[d]{.smallcaps} [pmf]{.smallcaps}s for charged membranes, and [S10](#pcbi.1005831.s011){ref-type="supplementary-material"} and [S11](#pcbi.1005831.s012){ref-type="supplementary-material"} Figs for 2[d]{.smallcaps} [pmf]{.smallcaps}s for neutral membranes.

![The free energy surfaces for [npc]{.smallcaps}2 binding to membranes.\
A) Potential of mean force ([pmf]{.smallcaps}) profiles shown as a function of min *z*~*r*~, which stands for the minimum of the protein C~*α*~ *z*-coordinates for the residue *r*. The origin (*z* = 0) is set to [com]{.smallcaps}~*z*~ of the upper leaflet P atoms. B) [pmf]{.smallcaps} surfaces shown as a function of min *z*~*r*~ and *ϕ* for anionic membranes. Contours were plotted every 2 kJ/mol increments. The two binding orientations are marked with dashed lines. The thumbnail images of [npc]{.smallcaps}2 structure for the corresponding orientations are shown on the upper left corner for *Prone mode* and on the upper right corner for *Supine mode*. See [S9 Fig](#pcbi.1005831.s010){ref-type="supplementary-material"} for the local errors and [S1 Fig](#pcbi.1005831.s002){ref-type="supplementary-material"} for the [pmf]{.smallcaps} projected onto \|*z*\|. The labels indicate membrane content in molar fractions for a mixture of [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps}, and the corresponding system numbers ([Table 1](#pcbi.1005831.t001){ref-type="table"}) are provided in parentheses. The local errors are given in [S9 Fig](#pcbi.1005831.s010){ref-type="supplementary-material"}.](pcbi.1005831.g003){#pcbi.1005831.g003}

Here, we discuss the general features of [npc]{.smallcaps}2-membrane binding. In agreement with the above-discussed unbiased simulations, the results show enhanced [npc]{.smallcaps}2 binding only to anionic membranes rich in [bmp]{.smallcaps}. In neutral membranes without [bmp]{.smallcaps} ([bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps} = 0:10:0:0:90 (1), 0:35:0:0:65 (System 2), and 0:10:20:0:70 (System 3)), the affinity for the membranes is low ([Fig 3A](#pcbi.1005831.g003){ref-type="fig"} and [S1A Fig](#pcbi.1005831.s002){ref-type="supplementary-material"}). The binding to neutral membranes is unspecific in terms of *ϕ* ([S10](#pcbi.1005831.s011){ref-type="supplementary-material"} and [S3](#pcbi.1005831.s004){ref-type="supplementary-material"} Figs) and *θ* ([S7 Fig](#pcbi.1005831.s008){ref-type="supplementary-material"}), as no particular binding orientation can be identified. In anionic membranes ([bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps} = 100:0:0:0:0 (System 4), 20:10:0:0:70 (System 5), 20:35:0:0:45 (System 6), 20:10:20:0:50 (System 7), and 0:10:0:20:70 (System 8)), on the other hand, we observe the two distinct high-affinity binding orientations (*ϕ* \>∼140° and *ϕ* \<∼40° in *Prone* and *Supine* modes, respectively) with overall enhanced affinity in *Supine mode* ([Fig 3B](#pcbi.1005831.g003){ref-type="fig"} and [S1B Fig](#pcbi.1005831.s002){ref-type="supplementary-material"}). The [pmf]{.smallcaps} profiles ([S5 Fig](#pcbi.1005831.s006){ref-type="supplementary-material"}) reveal a single specific high affinity binding orientation for the anionic membranes in terms of *θ* in a range of about 80° \< *θ* \< 100°.

*Supine mode* has generally lower free energies than *Prone mode* and is more plastic as indicated by the wider distribution of *ϕ* in *Supine mode* ([Fig 3](#pcbi.1005831.g003){ref-type="fig"} and [S1 Fig](#pcbi.1005831.s002){ref-type="supplementary-material"}). This also suggests that *Supine mode* is more flexible in terms of membrane-interacting residues and may be better described as a membrane-adsorbed state rather than as a specific membrane-bound state. On the other hand, *Prone mode* is characterized by a tighter distribution of *ϕ* and deeper insertion into the membrane ([Fig 3B](#pcbi.1005831.g003){ref-type="fig"}). This deeply inserted state, also apparent in 1[d]{.smallcaps} [pmf]{.smallcaps} profiles ([Fig 3A](#pcbi.1005831.g003){ref-type="fig"}), is uniquely associated with *Prone mode* and forms by the membrane insertion of a loop (V59-M60-G61-I62-P63-V64-P65) at the opening of the cholesterol-binding pocket. From here on, we refer to this hydrophobic loop as the *membrane insertion loop* ([mil]{.smallcaps}).

The position of the cholesterol-binding pocket and three residues (F66, V96, and T100) that act as gates in sterol transfer \[[@pcbi.1005831.ref018]\] with respect to the membrane surface, as well as the membrane insertion of the loop strongly suggest that *Prone mode* is the conductive state for cholesterol uptake/release.

Because the interconversion between *Prone* and *Supine* modes can determine the efficiency of cholesterol uptake/release, it is potentially an important process for [npc]{.smallcaps}2 function. The interconversion can take place by protein detaching from the membrane and reattaching in either of the orientations. This process requires surpassing the barrier equal to the free energy of membrane binding, which in [BMP]{.smallcaps}-containing membranes is typically 7 − 15 kJ/mol and hence quite large ([Table 1](#pcbi.1005831.t001){ref-type="table"}). Alternatively, the protein could roll around its long axis without detaching from the membrane. The latter process has a barrier of about 6 − 7 kJ/mol (about 2.5 to 3 *k*~B~*T*) along *ϕ* ([Fig 3B](#pcbi.1005831.g003){ref-type="fig"}), which is quite low compared to thermal energy.

We conclude that [npc]{.smallcaps}2 changes the binding orientation by rocking around its long axis while staying adsorbed on the membrane surface.

[bmp]{.smallcaps} promotes formation of *Prone mode* and is required for membrane anchoring {#sec006}
-------------------------------------------------------------------------------------------

[bmp]{.smallcaps} is known to improve [npc]{.smallcaps}2-mediated cholesterol transfer between membranes \[[@pcbi.1005831.ref027]\]. To investigate the effect of [bmp]{.smallcaps} on the free energy of [npc]{.smallcaps}2-membrane binding, we performed membrane binding free energy simulations for both [npc]{.smallcaps}2^*apo*^ and [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^ in the presence of [bmp]{.smallcaps}. We focus our discussion here on the investigations with the anionic [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps} = 20:10:0:0:70 (System 5) mixture together with the neutral membranes that do not contain [bmp]{.smallcaps} ([Table 1](#pcbi.1005831.t001){ref-type="table"}). Both [npc]{.smallcaps}2^*apo*^ and [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^ bind strongly in two specific binding orientations to [bmp]{.smallcaps} membranes, the binding free energies being around or larger than Δ*G* = −11 kJ/mol. In neutral membranes, the binding affinity is much lower (Δ*G* = −3 to −4 kJ/mol) and manifests unspecific adsorption in terms of *ϕ* and *θ* as mentioned above ([S10](#pcbi.1005831.s011){ref-type="supplementary-material"}, [S3](#pcbi.1005831.s004){ref-type="supplementary-material"} and [S7](#pcbi.1005831.s008){ref-type="supplementary-material"} Figs). The 2[d]{.smallcaps} [pmf]{.smallcaps} in [Fig 3B](#pcbi.1005831.g003){ref-type="fig"} (1^st^ row) shows that *Prone mode* is almost as favorable as *Supine mode*, especially when [npc]{.smallcaps}2 is cholesterol-bound. Moreover, [bmp]{.smallcaps} also promotes membrane anchoring by the *membrane insertion loop* ([mil]{.smallcaps}) as evidenced by deeper inserted states captured in the [pmf]{.smallcaps} profiles.

In essence, [bmp]{.smallcaps} does not only improve [npc]{.smallcaps}2 adsorption onto the membrane surface, but it also promotes the binding mode (*Prone*) in which cholesterol uptake and release can take place, along with membrane anchoring by [mil]{.smallcaps}.

[bmp]{.smallcaps}'s effect on [npc]{.smallcaps}2-membrane binding is not only due to its negative charge {#sec007}
--------------------------------------------------------------------------------------------------------

The electrostatic potential profiles ([S12 Fig](#pcbi.1005831.s013){ref-type="supplementary-material"}) lack a substantial difference between membrane compositions that could explain how and why [npc]{.smallcaps}2, which has +4*e* at pH = 5 (see [S1 Text](#pcbi.1005831.s001){ref-type="supplementary-material"}), favors negatively charged [bmp]{.smallcaps}. To further test whether the effects of [bmp]{.smallcaps} on [npc]{.smallcaps}2-membrane binding are specific or can simply be attributed to its negative charge, we performed free energy simulations, where [bmp]{.smallcaps} is substituted with [dopg]{.smallcaps} ([bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps} = 0:10:0:20:70 (System 8)). Phosphatidylglycerol ([pg]{.smallcaps}) lipids are not only negatively charged, but they are also precursors in [bmp]{.smallcaps} synthesis \[[@pcbi.1005831.ref049]\]. Although the negative charge of [dopg]{.smallcaps} clearly enhances membrane adsorption (Δ*G* = −9 to −10 kJ/mol) when compared to the neutral membranes, the [dopg]{.smallcaps} membrane has ∼ 3 kJ/mol lower affinity for both [npc]{.smallcaps}2^*apo*^ and [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^ when compared to [bmp]{.smallcaps}-containing membranes ([Fig 3A](#pcbi.1005831.g003){ref-type="fig"} and [S1A Fig](#pcbi.1005831.s002){ref-type="supplementary-material"}). Moreover, [dopg]{.smallcaps} does not favor [npc]{.smallcaps}2-binding in *Prone mode* as strongly as [bmp]{.smallcaps}, and does not foster the penetration of the *membrane insertion loop* into the membrane ([Fig 3B](#pcbi.1005831.g003){ref-type="fig"}; last row).

Because [pg]{.smallcaps} cannot reproduce the effects of [bmp]{.smallcaps}, we conclude that specific [bmp]{.smallcaps}-[npc]{.smallcaps}2 interactions are important in both membrane binding and cholesterol uptake/release.

[npc]{.smallcaps}2-membrane binding is cholesterol dependent {#sec008}
------------------------------------------------------------

The higher cholesterol concentration is expected to shift the equilibrium between the [npc]{.smallcaps}2^*apo*^ and [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^ towards the cholesterol-bound state. We further hypothesized that cholesterol concentration in the membrane can also affect [npc]{.smallcaps}2-membrane binding properties. Increasing the cholesterol concentration from 10 to 35 mol% in the presence of 20 mol% [bmp]{.smallcaps} ([bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps} = 20:10:0:0:70 (System 5) and 20:35:0:0:45 (System 6); see [Table 1](#pcbi.1005831.t001){ref-type="table"}) enhances membrane adsorption for [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^ by ∼3 kJ/mol (at min *z*~*r*~ = ∼ 3Å) without affecting that of [npc]{.smallcaps}2^*apo*^. However, higher cholesterol concentration has the opposite effect for the deeper inserted binding mode of [npc]{.smallcaps}2 (*Prone mode*). The deeper inserted state (around min *z*~*r*~ = −6 Å) is destabilized by ∼5 kJ/mol for [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^, while it is stabilized by ∼3 kJ/mol for [npc]{.smallcaps}2^*apo*^ ([Fig 3A](#pcbi.1005831.g003){ref-type="fig"}). The same effect can be more clearly seen in 2[d]{.smallcaps} [pmf]{.smallcaps} profiles ([Fig 3B](#pcbi.1005831.g003){ref-type="fig"}, 1^st^ and 2^nd^ rows). Comparing 10 mol% and 35 mol% [chol]{.smallcaps} membranes, the minimum for *Prone mode* shifts up towards the membrane surface and its free energy is increased in [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^, while it is shifted downwards in [npc]{.smallcaps}2^*apo*^. In other words, while both [npc]{.smallcaps}2^*apo*^ and [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^ adsorb on the [bmp]{.smallcaps}-rich membranes with high affinity, the higher [chol]{.smallcaps} concentration shifts the free energy minimum towards the deeper inserted *Prone mode* in [npc]{.smallcaps}2^*apo*^ and away from it in [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^.

This result implies that the cholesterol levels in the internal membranes of late endosomes/lysosomes can affect the rate of [npc]{.smallcaps}2-mediated cholesterol transport by affecting the equilibrium between *Prone* and *Supine* modes, taking into account that deeper inserted *Prone mode* is conductive for cholesterol uptake and release.

Sphingomyelin impairs [npc]{.smallcaps}2-membrane binding in *Prone mode* {#sec009}
-------------------------------------------------------------------------

[sm]{.smallcaps} is one of the components of the suborganelle fractions of late endosomes \[[@pcbi.1005831.ref022]\]. Furthermore, [sm]{.smallcaps} has been shown to strongly inhibit cholesterol-transport by [npc]{.smallcaps}2 \[[@pcbi.1005831.ref027]\]. To investigate if and how [sm]{.smallcaps} affects [npc]{.smallcaps}2-membrane binding, we performed unbiased and free energy simulations to membranes containing 20 mol% [sm]{.smallcaps} in the presence and absence of [bmp]{.smallcaps} ([bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps} = 20:10:20:0:50 (System 7) and 0:10:20:0:70 (System 3); see [Table 1](#pcbi.1005831.t001){ref-type="table"}).

Like all other neutral membranes, [npc]{.smallcaps}2 has small affinity for non-specific adsorption onto the [sm]{.smallcaps}-membrane surface (Δ*G* = −3 to −4 kJ/mol; [Fig 4A](#pcbi.1005831.g004){ref-type="fig"}). The [bmp]{.smallcaps}-[sm]{.smallcaps} membrane, on the other hand, has approximately the same affinity for [npc]{.smallcaps}2 when compared to [bmp]{.smallcaps}-membrane without [sm]{.smallcaps} but with 10 mol% [chol]{.smallcaps} (Δ*G* = −12 to −13 kJ/mol; [Fig 4A](#pcbi.1005831.g004){ref-type="fig"}). However, the important observation is that the deeper inserted binding mode of [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^ ([Fig 4A](#pcbi.1005831.g004){ref-type="fig"}) is clearly inhibited by [sm]{.smallcaps}. Meanwhile, the deeper inserted state for [npc]{.smallcaps}2^*apo*^ has ∼4 kJ/mol higher free energy in all 20 mol% [bmp]{.smallcaps} membranes regardless of the presence of [sm]{.smallcaps}. Therefore, [sm]{.smallcaps} does not have any clear effect on membrane binding of [npc]{.smallcaps}2^*apo*^ ([Fig 4A](#pcbi.1005831.g004){ref-type="fig"}). These observations are also confirmed by comparing the 2[d]{.smallcaps} [pmf]{.smallcaps} data ([Fig 4B](#pcbi.1005831.g004){ref-type="fig"}) for [sm]{.smallcaps}-containing and [sm]{.smallcaps}-free membranes, as well as the lack of adsorption in *Supine mode* to [sm]{.smallcaps}-containing membranes in unbiased simulations ([Table 1](#pcbi.1005831.t001){ref-type="table"}).

![Normalized contact frequency analysis ([ncf]{.smallcaps}).\
A) The black rectangles show the [ncf]{.smallcaps} averaged over all [bmp]{.smallcaps} mixtures ([bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps} = 20:10:0:0:70 (System 5), 20:35:0:0:45 (System 6) and 20:10:20:0:50 (System 7)), and the gray bars show the standard deviation. B) Representative snapshots showing [npc]{.smallcaps}2 interacting with [bmp]{.smallcaps} in *Prone mode* (left) and *Supine mode* (right). The protein is colored based on the [ncf]{.smallcaps} and the residues with [ncf]{.smallcaps} \> 0.4 are shown in licorice and labeled.](pcbi.1005831.g004){#pcbi.1005831.g004}

The results offer a mechanism as to how [sm]{.smallcaps} inhibits [npc]{.smallcaps}2-mediated cholesterol transport: [sm]{.smallcaps} can hinder cholesterol transfer between membranes by interfering with formation of the deeper inserted *Prone mode*, and thus, the cholesterol release from [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^. Since [bmp]{.smallcaps}-[sm]{.smallcaps} membranes have similar affinity to those with only [bmp]{.smallcaps}, the [sm]{.smallcaps}-containing membrane fractions of the internal lysosomal/late endosomal membranes may arrest substantial amount of [npc]{.smallcaps}2 in non-conductive *Supine mode*. This can, in turn, reduce the effective concentration of [npc]{.smallcaps}2 available for cholesterol exchange, hindering it even further.

Specific [npc]{.smallcaps}2-[bmp]{.smallcaps} interactions in *Prone mode* are based on the *membrane insertion loop* {#sec010}
---------------------------------------------------------------------------------------------------------------------

Having identified two functional binding modes for [npc]{.smallcaps}2-membrane binding and the importance of [bmp]{.smallcaps} in the process, we moved on to characterize specific interactions between [bmp]{.smallcaps} and [npc]{.smallcaps}2 using all membrane-binding free energy simulations with [bmp]{.smallcaps}-membranes. To this end, for each orientation in each [bmp]{.smallcaps}-membrane free energy simulation, we calculated *the normalized contact frequency* ([ncf]{.smallcaps}) ([S1 Text](#pcbi.1005831.s001){ref-type="supplementary-material"}). For a given residue *r*, [ncf]{.smallcaps} describes the contact frequency with [bmp]{.smallcaps} compared to the total number of contacts with any lipids in a membrane. [ncf]{.smallcaps} captures if and how much [bmp]{.smallcaps}-[npc]{.smallcaps}2 interactions are enhanced with respect to those with other lipids in the membrane. In other words, for a particular residue, the values of [ncf]{.smallcaps} close to 1 indicate that its contact with [bmp]{.smallcaps} is likely specific, while values close to 0 indicate that either the contact was not observed or it is unspecific.

[Fig 4A](#pcbi.1005831.g004){ref-type="fig"} shows the average of [ncf]{.smallcaps} over all [bmp]{.smallcaps}-membrane free energy simulations, and its standard deviation. In *Prone mode*, the loop at the opening of the cholesterol-binding pocket (V59-M60-G61-I62-P63-V64-P65) along with several residues nearby in sequence has the highest probability of interacting with [bmp]{.smallcaps} when compared to any other lipid in the membrane ([Fig 4A](#pcbi.1005831.g004){ref-type="fig"}). Moreover, a stretch of residues from 96--108 that also line the bottom surface in *Prone mode*, as well as several residues around R118, are involved in [bmp]{.smallcaps} contacts. Likely due to the flexibility of the N-terminus, residues around K4 also form substantial contacts with [bmp]{.smallcaps}. Moreover, F66, V96, and T100, which have been previously implicated as "reversible gate keepers" in sterol uptake and release \[[@pcbi.1005831.ref018]\], are among the residues with enhanced specificity to [bmp]{.smallcaps} in *Prone mode*. This further supports the role of *Prone mode* and [bmp]{.smallcaps} in cholesterol transport.

Comparison of [Fig 4A and 4B](#pcbi.1005831.g004){ref-type="fig"} panels shows that *Supine mode* has considerably fewer specific contacts with [bmp]{.smallcaps} than *Prone mode*. The comparison also reveals that the residues in contact with [bmp]{.smallcaps} in the two orientations are anti-correlated except near the termini. This is partly the effect of the restricted definition of *Supine mode* used here. *Supine mode* appears to be more plastic than *Prone mode* and the low free energy region near *Supine mode* extends up to ∼100°.

While many polar and non-polar residues contact [bmp]{.smallcaps} in *Prone mode*, only positively charged residues interact with [bmp]{.smallcaps} in *Supine mode*. This is due to the deeper insertion taking place in *Prone mode*, which is stabilized by several nearby charged residue-[bmp]{.smallcaps} interactions ([Fig 4](#pcbi.1005831.g004){ref-type="fig"}). Moreover, H56, which is highly conserved among homologs of [npc]{.smallcaps}2, is likely involved in deep insertion of the loop into the membrane by interacting strongly with [bmp]{.smallcaps}. This residue is protonated in all of our simulations based on the p*K*~*a*~ estimations done on the crystal structures \[[@pcbi.1005831.ref003], [@pcbi.1005831.ref044]\]. Indeed, H56 may play a key role in the pH dependence of [npc]{.smallcaps}2-mediated cholesterol transport \[[@pcbi.1005831.ref027]\] by modulating the formation of deeply inserted *Prone mode*.

Membrane lipids affect [npc]{.smallcaps}2-binding by altering the accessibility of [bmp]{.smallcaps} {#sec011}
----------------------------------------------------------------------------------------------------

Having established the role of [bmp]{.smallcaps} and its interaction with the *membrane insertion loop* for the formation of *Prone mode*, we also explored how the lipids studied here, in particular [chol]{.smallcaps} and [sm]{.smallcaps}, can affect this interaction at the molecular level. We showed that [chol]{.smallcaps} concentration differentially affects *Prone mode* in [npc]{.smallcaps}2^*apo*^ and [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^, and [sm]{.smallcaps} hinders its formation. An important stabilizing factor for *Prone mode* is the anchoring by the *membrane insertion loop*, which is further stabilized by [bmp]{.smallcaps}. The insertion, on the other hand, is only favorable if the desolvation penalty of the loop and the cavity it inserts into are compensated by favorable interactions with lipids.

To indirectly assess the penalty of membrane insertion due to [chol]{.smallcaps} and [sm]{.smallcaps}, we use the quantity [sasa]{.smallcaps}-ratio = [sasa]{.smallcaps}~[mil]{.smallcaps}~/[sasa]{.smallcaps}~W~. Here, [sasa]{.smallcaps}~W~ stands for the solvent accessible surface area ([sasa]{.smallcaps}) estimated using a probe with a radius of 0.14 nm to approximate water as solvent; and [sasa]{.smallcaps}~[mil]{.smallcaps}~ stands for [sasa]{.smallcaps} estimated using a probe with a radius of 0.58 nm to approximate the *membrane insertion loop* ([mil]{.smallcaps}). The probe radius of 0.58 nm for [mil]{.smallcaps} is approximated by $R_{min} = 0.066M^{\frac{1}{2}}$ \[[@pcbi.1005831.ref050]\], where mass, *M*, of [mil]{.smallcaps} is 694 Da. Note that *R*~*min*~ is the minimum radius of a sphere in which the protein of mass *M* can fit \[[@pcbi.1005831.ref050]\]. We calculated the [sasa]{.smallcaps}-ratio (reported as mean ± standard deviation) for all the lipid components collectively ([sasa]{.smallcaps}-ratio^membrane^) and for only [bmp]{.smallcaps} in the context of all lipid components ([sasa]{.smallcaps}-ratio^[bmp]{.smallcaps}^). For calculations, we used only free energy simulation trajectories (the last 50--100 ns), where the protein ([npc]{.smallcaps}2^*apo*^ or [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^) is kept at a non-interacting distance to the membrane (*i* = 45--53, [Fig 2](#pcbi.1005831.g002){ref-type="fig"}) to ensure that membranes are unaffected by the protein.

[sasa]{.smallcaps}-ratio is a dimensionless quantity (within the interval of \[0, 1\]) that shows the relative accessibility of the surfaces by [mil]{.smallcaps} when compared to water, with values of ∼1 implying almost equal accessibility by [mil]{.smallcaps} and water, and values of ∼0 implying almost no accessibility by [mil]{.smallcaps}. The three studied systems ([bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps} = 20:10:0:0:70 (System 5), 20:35:0:0:45 (System 6), and 20:10:20:0:50 (System 7)) have a similar [sasa]{.smallcaps}-ratio^membrane^ (the values being 0.53 ± 0.02, 0.51 ± 0.02, and 0.51 ± 0.02, respectively). This shows that the [sasa]{.smallcaps}-ratio does not depend substantially on the membrane size and composition, when all the membrane components are considered collectively. Interestingly, we found that increasing [chol]{.smallcaps} concentration from 10 to 35 mol % increased the [sasa]{.smallcaps}-ratio^[bmp]{.smallcaps}^ from 0.23 ± 0.06 to 0.32 ± 0.05. Meanwhile, inclusion of [sm]{.smallcaps} decreased the [sasa]{.smallcaps}-ratio^[bmp]{.smallcaps}^ to 0.20 ± 0.05. That is, [chol]{.smallcaps} enhances [bmp]{.smallcaps} presentation to [mil]{.smallcaps}, while [sm]{.smallcaps} decreases it.

Overall, this analysis suggests that [bmp]{.smallcaps} presentation through crevices on a membrane surface contributes strongly to formation of the deep-inserted *Prone mode*, and that [bmp]{.smallcaps} presentation is modulated by the relative concentrations of [chol]{.smallcaps} and [sm]{.smallcaps}. While [chol]{.smallcaps} elevates [bmp]{.smallcaps} presentation, [sm]{.smallcaps} has an opposite effect.

Membrane-binding mode and membrane composition modulate the cholesterol-binding affinity of [npc]{.smallcaps}2 {#sec012}
--------------------------------------------------------------------------------------------------------------

The thermodynamic cycle shown in [Fig 5A](#pcbi.1005831.g005){ref-type="fig"} allows us to infer about the cholesterol-binding free energy difference between the solvated (aqueous (aq)) and membrane-bound forms of [npc]{.smallcaps}2, which can be expressed as $$\Delta\Delta G^{\text{CHOL} - \text{binding}} = \Delta G_{\text{membrane-bound}}^{apo\rightarrow\text{CHOL-bound}} - \Delta G_{\text{aq}}^{apo\rightarrow\text{CHOL-bound}}$$ $$= \Delta G_{\text{aq}\rightarrow\text{membrane-bound}}^{\text{CHOL} - \text{bound}} - \Delta G_{\text{aq}\rightarrow\text{membrane-bound}}^{apo},$$ where the apo → [chol]{.smallcaps}-bound and aq → membrane-bound transformations are shown with dashed and solid arrows, respectively, in [Fig 5A](#pcbi.1005831.g005){ref-type="fig"}. Expressing the aq → membrane-bound transformation in terms of min *z*~*r*~, we can calculate the relative cholesterol binding free energy, ΔΔ*G*^[chol]{.smallcaps}-bound^(min *z~r~*) ([Fig 5B](#pcbi.1005831.g005){ref-type="fig"}), by subtracting the [pmf]{.smallcaps} data for [npc]{.smallcaps}2^*apo*^ from those of [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^ shown in [Fig 3A](#pcbi.1005831.g003){ref-type="fig"}.

![Cholesterol-binding free energy change upon membrane binding.\
A) Thermodynamic cycle for the estimation of cholesterol binding free energy change. Solid arrows represent the transformations performed in this work and dashed arrows represent the alternative transformations. B) The cholesterol binding free energy change as a function of min *z*~*r*~, calculated by ΔΔ*G*^[chol]{.smallcaps}-b.^(min *z~r~*) = Δ*G*^[chol]{.smallcaps}-b.^(min *z~r~*) − Δ*G*^*apo*^(min *z~r~*). The labels indicate membrane content in molar fractions for a mixture of [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps}, and the corresponding system numbers ([Table 1](#pcbi.1005831.t001){ref-type="table"}) are provided in parentheses.](pcbi.1005831.g005){#pcbi.1005831.g005}

The cholesterol binding affinity of [npc]{.smallcaps}2 is modulated by the composition of the membrane and the binding mode of [npc]{.smallcaps}2. For most of the studied membrane systems, the cholesterol binding free energy decreases upon formation of the deeply-inserted state of [npc]{.smallcaps}2 ([Fig 5](#pcbi.1005831.g005){ref-type="fig"}). However, for the low cholesterol [bmp]{.smallcaps}-membrane ([bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps} = 20:10:0:0:70 (System 5)), the cholesterol binding affinity clearly increases up to ∼5 kJ/mol in the deeply-inserted membrane-bound state. The cholesterol-binding affinities are not affected in the shallow binding *Prone mode*, since the cholesterol-binding pocket is still exposed to bulk solvent. However, the deeply inserted state both changes the environment of the hydroxyl group of cholesterol by exposing it to the lipid head groups and likely affects the cholesterol-binding pocket.

In summary, membrane composition does not only determine the membrane binding properties of [npc]{.smallcaps}2, but also its cholesterol-binding affinity.

Discussion {#sec013}
==========

We performed an extensive set of atomistic simulations of the cholesterol-carrier protein [npc]{.smallcaps}2. The work done provides insights into the membrane-binding mechanism of [npc]{.smallcaps}2, its dependence on specific lipids, and the cholesterol transfer process associated with [npc]{.smallcaps}2.

The results from the interactions between [bmp]{.smallcaps}-containing membranes and [npc]{.smallcaps}2 are summarized schematically in [Fig 6](#pcbi.1005831.g006){ref-type="fig"}. A simplified putative cycle for cholesterol transport between cholesterol-poor and cholesterol-rich membranes that contain [bmp]{.smallcaps} is represented by solid arrows. In this cycle, [npc]{.smallcaps}2^*apo*^ (i) binds a cholesterol-rich membrane in *Prone mode*, (ii) loads cholesterol, (iii) detaches from the membrane, (iv) binds a cholesterol-poor membrane in *Prone mode*, (v) unloads cholesterol, and (vi) detaches from the membrane. Based on this schematic, the interconversion between the *deeply-inserted* and the *surface-adsorbed* states, which have a free energy barrier of ∼6 − 7 kJ/mol depending on the membrane composition, competes with processes that are conductive to cholesterol exchange between membranes. [npc]{.smallcaps}2-[sm]{.smallcaps} membrane binding also competes with these processes by favoring the surface adsorbed states over the deeply inserted states.

![Schematic representation of the membrane binding of [npc]{.smallcaps}2.\
The thumbnail images for [npc]{.smallcaps}2^*apo*^ (green) and [npc]{.smallcaps}2^[chol]{.smallcaps}-bound^ (red) are placed on the *y*-axis based on the [pmf]{.smallcaps} data ([Fig 3A](#pcbi.1005831.g003){ref-type="fig"}) of the [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps} = 20:10:0:0:70 (System 5) (low [chol]{.smallcaps}), [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps} = 20:35:0:0:45 (System 6) (high [chol]{.smallcaps}), and [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps} = 20:10:20:0:50 (System 7) (low [chol]{.smallcaps} with [sm]{.smallcaps}) systems. A putative cycle for transferring cholesterol from high [chol]{.smallcaps} to low [chol]{.smallcaps} membranes are indicated by thick arrows. The competing processes (the interconversion between the two binding modes and binding to [sm]{.smallcaps}-containing membranes) are indicated by dashed arrows.](pcbi.1005831.g006){#pcbi.1005831.g006}

We propose a concerted regulatory mechanism of [npc]{.smallcaps}2 by [bmp]{.smallcaps} and [sm]{.smallcaps}. In this mechanism, [npc]{.smallcaps}2-membrane binding is facilitated and stabilized by direct interaction of [npc]{.smallcaps}2 with [bmp]{.smallcaps}. While the negative charge of [bmp]{.smallcaps} is involved in pulling [npc]{.smallcaps}2 to the membrane surface, specific interactions, such as those with H56, are necessary especially for the formation of *Prone mode* and the insertion of the *membrane insertion loop*. Meanwhile, [sm]{.smallcaps} regulates membrane binding indirectly by modulating the presentation of [bmp]{.smallcaps} to [npc]{.smallcaps}2. Interestingly, this indirect regulation does not necessarily change the affinity of [npc]{.smallcaps}2 to the membrane, but instead alters its propensity to bind in *Prone mode*.

Our results have various implications about the mechanism and regulation of [npc]{.smallcaps}2-mediated cholesterol transport. Abdul-Hammed et al. have performed assays that showed [bmp]{.smallcaps} to enhance both processes, but [sm]{.smallcaps} to inhibit them \[[@pcbi.1005831.ref027]\]. Since the productive configuration for cholesterol exchange between the membranes and [npc]{.smallcaps}2 is likely to be *Prone mode*, our results explain the underlying molecular mechanism for the roles of [bmp]{.smallcaps} and [sm]{.smallcaps}. Essentially, [bmp]{.smallcaps} supports [npc]{.smallcaps}2-mediated cholesterol transport by enhancing binding in *Prone mode*, and [sm]{.smallcaps} in turn inhibits it by the reverse mechanism. Besides, acid sphingomyelinase regulates [npc]{.smallcaps}2-mediated cholesterol transport by converting [sm]{.smallcaps} to ceramide \[[@pcbi.1005831.ref051]\]. The functional role of these two different binding orientations in cholesterol transport can be explained by this regulation mechanism. That is, cholesterol transport rate can be controlled by the composition of the membrane interacting with [npc]{.smallcaps}2 such that [npc]{.smallcaps}2-binding in *Prone mode* is favored, or disfavored. Another functional role for two distinct high affinity surfaces of the protein is potentially related to [npc]{.smallcaps}2's fusogenic function and its regulation \[[@pcbi.1005831.ref027]\].

[npc]{.smallcaps}2 contains many acidic and basic residues, mainly on its surface. The bovine and human orthologs of the protein have a net charge of +2*e* and +1*e*, respectively, based on the number of charged residues. In the low pH of lysosomes, at least some acidic residues and histidines are expected to be protonated attaining neutral or positive charges and increasing the overall positive charge of the protein. Indeed, in our simulations, we used bovine [npc]{.smallcaps}2 protonated at E110 (Q in human), H31 (S in human) and H56 (strongly conserved) based on p*K*~a~ estimations on the crystal structures to approximate an environmental pH of ∼5. However, our simulations do not account for dynamic shifts in p*K*~a~ due to changes in the local environment. Several acidic residues are located on the membrane interacting surfaces in *Prone mode* and *Supine mode*. When [npc]{.smallcaps}2 adsorbs onto the membrane surface, the local electrostatic potential due to the anionic lipid head groups will increase the intrinsic p*K*~a~ of these residues. That is, some acidic residues can get protonated depending on the membrane composition and depending on where they are located with respect to the membrane in a particular membrane binding mode. This can, in turn, alter membrane binding modes and their affinities, especially in the anionic membranes. For example, D113, which is on the membrane-interacting surface in *Prone mode*, has been shown to be vital for cholesterol transport, but not for cholesterol binding \[[@pcbi.1005831.ref024]\]. The dynamic and differential protonation of residues like D113 may modulate [npc]{.smallcaps}2-binding to membranes with different compositions. Besides, they likely prevent very tight [npc]{.smallcaps}2-membrane binding. This is essential for efficient shuttling of [npc]{.smallcaps}2 between disconnected membranes to transport cholesterol.

Glycosylation of [npc]{.smallcaps}2 has been implicated in proper protein sorting, protection against degradation by the lysosomal enzymes, and in modulating cholesterol transfer rates \[[@pcbi.1005831.ref026]\]. Monoglycosylated (glycosylated at N39) and diglycosylated (glycosylated at both N39 and N116) forms of [npc]{.smallcaps}2 have been identified in lysosomes \[[@pcbi.1005831.ref026], [@pcbi.1005831.ref052]\]. Cholesterol transfer by the diglycosylated form has been shown to be slower than that by the monoglycosylated form \[[@pcbi.1005831.ref026]\], but the molecular mechanism accounting for the observed difference remains unknown. Based on our work, N39 and N116 are located on the membrane interacting surfaces in *Supine mode* and *Prone mode*, respectively. Glycosylation of N39 may destabilize *Supine mode* and shift the equilibrium towards *Prone mode*. This shift, in turn, may enhance cholesterol uptake and release, since this process presumably takes place in *Prone mode*, but not in *Supine mode*. On the other hand, glycosylation at N116 is likely to interfere with the membrane interactions in *Prone mode*, especially close to the C-terminal side of the protein ([Fig 4A](#pcbi.1005831.g004){ref-type="fig"}). Cholesterol uptake and release could still take place, albeit slower, because the stretch of residues in the proximity of the hydrophobic loop may still anchor the protein to the membrane.

In summary, our results provide an atom-scale mechanism that explains the differential regulatory roles of [bmp]{.smallcaps} and [sm]{.smallcaps} in [npc]{.smallcaps}2-membrane binding. [npc]{.smallcaps}2 binds a membrane in two different binding orientations depending on the lipid composition. [bmp]{.smallcaps} is required for [npc]{.smallcaps}2-membrane binding and cannot be substituted by other anionic lipids. On the other hand, [sm]{.smallcaps} counteracts [bmp]{.smallcaps} and hinders the formation of the deep-inserted mode that places the cholesterol-binding pocket in direct contact with the membrane surface and is conductive for cholesterol uptake/release.

Supporting information {#sec014}
======================

###### Supplementary text.

Detailed descriptions of [bmp]{.smallcaps} parametrization, simulation system preparation, free energy calculations and reweighting approach are given.

(PDF)
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Click here for additional data file.

###### The free energy surfaces for [npc]{.smallcaps}2 binding to membranes as a function of \|*z*\|.

The free energy surfaces for cholesterol-bound (left column) and *apo* (right column) [npc]{.smallcaps}2 binding to membranes with different compositions. A) Potential of mean force ([pmf]{.smallcaps}) profiles shown as a function of \|*z*\|. The band thickness displays the error. B) [pmf]{.smallcaps} surfaces shown as a function of \|*z*\| and *ϕ*. Contours were plotted every 2 kJ/mol increments. The two binding orientations are marked with dashed lines. The thumbnail images of [npc]{.smallcaps}2 structure for the corresponding orientations are shown on the upper left for *Prone mode* and upper right for *Supine mode*. The labels indicate membrane content in molar fractions for a mixture of [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps}, and the corresponding system numbers ([Table 1](#pcbi.1005831.t001){ref-type="table"}) are provided in parentheses. The local errors are given in [S2 Fig](#pcbi.1005831.s003){ref-type="supplementary-material"}.
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Click here for additional data file.

###### Local errors of \|*z*\| vs. *ϕ* free energy surfaces for anionic membranes.

Local errors of \|*z*\| vs. *ϕ* free energy surfaces for cholesterol-bound (left column) and *apo* (right column) [npc]{.smallcaps}2 binding to anionic membranes with indicated compositions. The two binding orientations are marked with dashed lines. The labels indicate membrane content in molar fractions for a mixture of [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps}, and the corresponding system numbers ([Table 1](#pcbi.1005831.t001){ref-type="table"}) are provided in parentheses.
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###### The \|*z*\| vs. *ϕ* free energy surfaces for neutral membranes.

The \|*z*\| vs. *ϕ* free energy surfaces for cholesterol-bound (left column) and *apo* (right column) [npc]{.smallcaps}2 binding to neutral membranes with indicated compositions. The two binding orientations are marked with dashed lines. The labels indicate membrane content in molar fractions for a mixture of [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps}, and the corresponding system numbers ([Table 1](#pcbi.1005831.t001){ref-type="table"}) are provided in parentheses. The local errors are given in [S4 Fig](#pcbi.1005831.s005){ref-type="supplementary-material"}.
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###### 

Click here for additional data file.

###### Local errors of \|*z*\| vs. *ϕ* free energy surfaces for neutral membranes.

Local errors of \|*z*\| vs. *ϕ* free energy surfaces for cholesterol-bound (left column) and *apo* (right column) [npc]{.smallcaps}2 binding to neutral membranes with indicated compositions. The two binding orientations are marked with dashed lines. The labels indicate membrane content in molar fractions for a mixture of [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps}, and the corresponding system numbers ([Table 1](#pcbi.1005831.t001){ref-type="table"}) are provided in parentheses.
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###### 

Click here for additional data file.

###### The \|*z*\| vs. *θ* free energy surfaces for anionic membranes.

The \|*z*\| vs. *θ* free energy surfaces for cholesterol-bound (left column) and *apo* (right column) [npc]{.smallcaps}2 binding to anionic membranes with indicated compositions. The labels indicate membrane content in molar fractions for a mixture of [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps}, and the corresponding system numbers ([Table 1](#pcbi.1005831.t001){ref-type="table"}) are provided in parentheses. The local errors are given in [S6 Fig](#pcbi.1005831.s007){ref-type="supplementary-material"}.
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###### 

Click here for additional data file.

###### Local errors of \|*z*\| vs. *θ* free energy surfaces for anionic membranes.

Local errors of \|*z*\| vs. *θ* free energy surfaces for cholesterol-bound (left column) and *apo* (right column) [npc]{.smallcaps}2 binding to anionic membranes with indicated compositions. The labels indicate membrane content in molar fractions for a mixture of [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps}, and the corresponding system numbers ([Table 1](#pcbi.1005831.t001){ref-type="table"}) are provided in parentheses.
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###### 

Click here for additional data file.

###### The \|*z*\| vs. *θ* free energy surfaces for neutral membranes.

The \|*z*\| vs. *θ* free energy surfaces for cholesterol-bound (left column) and *apo* (right column) [npc]{.smallcaps}2 binding to neutral membranes with indicated compositions. The labels indicate membrane content in molar fractions for a mixture of [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps}, and the corresponding system numbers ([Table 1](#pcbi.1005831.t001){ref-type="table"}) are provided in parentheses. The local errors are given in [S8 Fig](#pcbi.1005831.s009){ref-type="supplementary-material"}.
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###### 

Click here for additional data file.

###### Local errors of \|*z*\| vs. *θ* free energy surfaces for neutral membranes.

Local errors of \|*z*\| vs. *θ* free energy surfaces for cholesterol-bound (left column) and *apo* (right column) [npc]{.smallcaps}2 binding to neutral membranes with indicated compositions. The labels indicate membrane content in molar fractions for a mixture of [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps}, and the corresponding system numbers ([Table 1](#pcbi.1005831.t001){ref-type="table"}) are provided in parentheses.

(TIFF)

###### 

Click here for additional data file.

###### Local errors of min *z*~*r*~ vs. *ϕ* free energy surfaces.

Local errors of min *z*~*r*~ vs. *ϕ* free energy surfaces for cholesterol-bound (left column) and *apo* (right column) [npc]{.smallcaps}2 binding to charged membranes with indicated compositions. The two binding orientations are marked with dashed lines. The labels indicate membrane content in molar fractions for a mixture of [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps}, and the corresponding system numbers ([Table 1](#pcbi.1005831.t001){ref-type="table"}) are provided in parentheses.
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###### 

Click here for additional data file.

###### The min *z*~*r*~ vs. *ϕ* free energy surfaces for neutral membranes.

The min *z*~*r*~ vs. *ϕ* free energy surfaces for cholesterol-bound (left column) and *apo* (right column) [npc]{.smallcaps}2 binding to neutral membranes with the indicated compositions. The two binding orientations are marked with dashed lines. The labels indicate membrane content in molar fractions for a mixture of [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps}, and the corresponding system numbers ([Table 1](#pcbi.1005831.t001){ref-type="table"}) are provided in parentheses. The local errors are given in [S11 Fig](#pcbi.1005831.s012){ref-type="supplementary-material"}.
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###### 

Click here for additional data file.

###### Local errors of min *z*~*r*~ vs. *ϕ* free energy surfaces for neutral membranes.

Local errors of min *z*~*r*~ vs. *ϕ* free energy surfaces for cholesterol-bound (left column) and *apo* (right column) [npc]{.smallcaps}2 binding to neutral membranes with indicated compositions. The two binding orientations are marked with dashed lines. The labels indicate membrane content in molar fractions for a mixture of [bmp]{.smallcaps}:[chol]{.smallcaps}:[sm]{.smallcaps}:[dopg]{.smallcaps}:[popc]{.smallcaps}, and the corresponding system numbers ([Table 1](#pcbi.1005831.t001){ref-type="table"}) are provided in parentheses.
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###### 

Click here for additional data file.

###### Electrostatic potential profiles.

Electrostatic potential profiles for the neutral (A) and charged (B) membranes. The profiles are calculated from free energy simulation trajectories (the last 100 ns), where the protein ([npc]{.smallcaps}2^*apo*^) is kept at a non-interacting distance to the membrane (*i* = 45--53, [Fig 2](#pcbi.1005831.g002){ref-type="fig"}) to ensure that membranes are unaffected by the protein. The trajectories were first centered based membrane [com]{.smallcaps} and then, the electric field calculated by `gmx potential` tool included in [gromacs]{.smallcaps} 5.0 \[[@pcbi.1005831.ref029]\] is averaged over the upper and lower halves of the box for symmetry. The electric field is then integrated to get the electrostatic potential profiles for each simulation. The profiles were averaged over all relevant simulations of a particular system and the band thickness displays their standard error. The location of the membrane P atoms is indicated with gray bands.
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###### 

Click here for additional data file.
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